Think twice before you refer patients for urine drug tests

Why This Topic Matters

Understanding the compliance risks around drug testing referrals helps practices reduce audit exposure and align ordering patterns with Medicare expectations. The article is relevant to organizations managing presumptive and definitive urine drug testing, referral workflows, and documentation of medical necessity.

Article Sections

1. Billing and referral oversight concerns

   Introduces the compliance issue and explains that scrutiny can extend to both billing entities and providers who refer patients for testing.

2. Comparative billing report context

   Summarizes the report discussed in the article and its focus on providers involved in drug testing claims and referrals.

3. Hypothetical referral scenarios

   Presents several example situations involving urine drug testing workflows and the general concerns raised by each scenario.

4. Monitoring, improper payment findings, and enforcement actions

   Reviews reported error-rate findings, fraud concerns, and recent legal actions involving drug testing referral schemes.

5. Compliance reminder

   Closes with a reminder to keep referrals medically necessary and consistent with current Medicare guidance.